Threshold Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Threshold Pharmaceuticals ( THLD) is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors as novel treatments for patients living with cancer. This stock is trading up 4.6% at $8.33 in recent trading.

Today's Range: $8.27-$8.77

52-Week Range: $1.18-$8.50

Volume: 4.4 million

Three-Month Average Volume: 3.1 million

>>7 Cancer Drug Stocks to Know Right Now

From a technical perspective, THLD is ripping higher today on monster volume, and the stock has now entered new 52-week high territory.

Traders should continue to look for long-biased trades as long as THLD can manage to close near its daily highs, and well above today's low of $8.27. If we get that action, then look for THLD to tag $10 in the very near future. The probability if $10 getting hit will increase as long as THLD is trending above $8.27 with strong upside volume flows.

If you liked this article you might like

One Reason Why Threshold Pharma (THLD) Stock Is Jumping Today

5 Breakout Stocks Under $10 Set to Soar

CytRx Bear Thesis Explained: Why Sarcoma Drug Trial Will Fail

2 'Rules of the Road' for Biotech Investing

2 'Rules of the Road' for Biotech Investing